摘要
目的观察通心络胶囊对不稳定型心绞痛患者的疗效和对C反应蛋白的影响。方法 82例患者随机分为治疗组和对照组,治疗组在对照组常规治疗的基础上加服通心络胶囊,疗程均为4周。分别于治疗前和治疗4周后观察病情变化并检测C反应蛋白。结果两组治疗后病情较前均有好转、C反应蛋白较治疗前均降低(P<0.01);治疗组疗效较对照组为好,(P<0.05);C反应蛋白差值较对照组大(P<0.05)。结论通心络胶囊治疗不稳定型心绞痛疗效显著。
Objective To observe the effect of Tongxinluo Capsule on the therapeutic effect and C - reactive protein(CRP) in patients with unstable angina pectoris. Methods 82 cases with unstable angina pectoffs were randomly divided into two groups: the control group and the treatment group. 40 cases in the control group were treated by routine therapy; 42 cases in the treatment group, were treated with Tongxinluo Capsule on the basis of routine therapy, with a treatment course of 4 weeks for both groups. To observe the therapeutic effect and the CRP 4 weeks before and after treatment in both groups. Result The therapeutic effect was better than before and CRP decreased significiantly after treatment in both groups (P 〈 0. 01 ). The therapeutic effect in treatment group was significantly superior to that of the control group (P 〈 0. 05 ). CRP difference in treatment group was obviously greater than that of control group ( P 〈 0. 05 ). Conclusion Tongxinluo Capsule is effective in treating unstable angina pectoris.
出处
《中国医学创新》
CAS
2008年第35期18-19,共2页
Medical Innovation of China
关键词
心绞痛
通心络胶囊
C反应蛋白
Angina pectoris
Tongxinluo capsule
C - reactive protein